Statistics for Leveraging GWAS data derived from a large cooperative group trial to assess the risk of taxane-induced peripheral neuropathy (TIPN) in patients being treated for breast cancer: Part 2—functional implications of a SNP cluster associated with TIPN risk in patients being treated for breast cancer
Total visits
| views | |
|---|---|
| Leveraging GWAS data derived from a large cooperative group trial to assess the risk of taxane-induced peripheral neuropathy (TIPN) in patients being treated for breast cancer: Part 2—functional implications of a SNP cluster associated with TIPN risk in patients being treated for breast cancer | 0 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:168916c0-5a7c-4412-a14d-1ab9a456866e | 7 |
| java.util.UUID:8628ca21-8c07-43f0-83b6-9d925c0e647f | 6 |
| java.util.UUID:3fa4729a-0b9a-4b97-8036-8bb1203d533d | 4 |
| Lustberg2023Leveraging-AAM.pdf | 2 |